Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human Syntaxin 1a ELISA Kit (AC3488)
Cat.#: ASET-2077
Specifications
Description Human Syntaxin 1a ELISA Kit allows for the in vitro quantitative determination of human Syntaxin 1a concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.094 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 0.156-10 ng/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-2375 Human CDNF ELISA Kit (AC3786) Quantitative inquiry ASET-2141 Mouse AKR7A2 ELISA Kit (AC3552) Quantitative inquiry ASET-1052 Human PDE6B ELISA Kit (AC2463) Quantitative inquiry ASET-1899 Human Vimentin ELISA Kit (AC3310) Quantitative inquiry ASET-1804 Mouse GABRA4 ELISA Kit (AC3215) Quantitative inquiry ASET-1554 Human Neurofilament Heavy Polypeptide ELISA Kit (AC2965) Quantitative inquiry ASET-2287 Human HMT ELISA Kit (AC3698) Quantitative inquiry ASET-2180 Rat alpha 2a Adrenergic Receptor ELISA Kit (AC3591) Quantitative inquiry ASET-2460 Human SHC ELISA Kit (AC3871) Quantitative inquiry ASET-1745 Canine IL-6 ELISA Kit (AC3156) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket